0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(12):1192. doi:10.1001/jama.2014.3085.

Viewpoint | 
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA. 2014;311(4):353-354. doi:10.1001/jama.2013.284531.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(3):233-234. doi:10.1001/jama.2013.284833.

Viewpoint | 
Jacob Doll, MD; Emily Zeitler, MD; Richard Becker, MD
JAMA. 2013;310(2):145-146. doi:10.1001/jama.2013.7155.

Special Communication | 
Bruce R. Korf, MD, PhD; Heidi L. Rehm, PhD
JAMA. 2013;309(14):1511-1521. doi:10.1001/jama.2013.3239.
Includes: CME

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(1):20. doi:10.1001/jama.2012.173440.

Viewpoint | 
Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH
JAMA. 2012;307(18):1921-1922. doi:10.1001/jama.2012.3516.

Editorial | 
Steven E. Nissen, MD
JAMA. 2011;306(24):2727-2728. doi:10.1001/jama.2011.1865.

Commentary | 
Amber L. Beitelshees, PharmD, MPH; David L. Veenstra, PharmD, PhD
JAMA. 2011;306(11):1252-1253. doi:10.1001/jama.2011.1343.

Commentary | 
David A. Mrazek, MD, FRCPsych; Caryn Lerman, PhD
JAMA. 2011;306(3):304-305. doi:10.1001/jama.2011.1010.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
Identification of a Novel Complex BRAF Mutation Associated With Major Clinical Response to Vemurafenib in a Patient With Metastatic Melanoma
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
Initial Exploration of Oral Pazopanib in Healthy Participants and Patients With Age-Related Macular Degeneration
Megan M. McLaughlin, MS; Marcella G. Paglione, PharmD; Jason Slakter, MD; et al.
JAMA Dermatology
Original Investigation  | 
The Role of Fcγ Receptor Polymorphisms in the Response to Anti–Tumor Necrosis Factor Therapy in Psoriasis:  A Pharmacogenetic Study
Marc Julià, MD; Antonio Guilabert, MD; Francisco Lozano, MD; et al.
JAMA Psychiatry
Original Investigation  | 
Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene With Prefrontal Function and Olanzapine Treatment
Giuseppe Blasi, MD, PhD; Caterina De Virgilio, PhD; Apostolos Papazacharias, MD; et al.